CVR number 26994756
Industry 86.9020 Other human health activities

MEDITAL KLINIK DANMARK ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  3.7% 1.4% 4.2% 4.6% 3.4%  
Credit score (0-100)  53 78 47 45 53  
Credit rating  BBB A BBB BBB BBB  
Credit limit (kDKK)  0.0 16.4 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 3,712 3,105 0  
Gross profit  1,141 2,089 1,518 1,202 1,159  
EBITDA  -101 685 135 -13.2 -2.7  
EBIT  -208 627 75.7 -75.9 -70.6  
Pre-tax profit (PTP)  -217.9 590.6 58.7 -94.0 -80.1  
Net earnings  -172.2 455.3 43.6 -128.1 -65.2  
Pre-tax profit without non-rec. items  -218 591 58.7 -94.0 -80.1  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  191 177 118 277 209  
Shareholders equity total  139 594 437 309 144  
Interest-bearing liabilities  154 244 340 366 351  
Balance sheet total (assets)  1,185 1,664 1,473 1,102 1,121  
Net Debt  -380 -1,065 -664 -303 -122  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 3,712 3,105 0  
Net sales growth  0.0% 0.0% 0.0% -16.3% -100.0%  
Gross profit  1,141 2,089 1,518 1,202 1,159  
Gross profit growth  77.4% 83.0% -27.4% -20.8% -3.6%  
Employees  2 2 2 0 0  
Employee growth %  0.0% 0.0% 0.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,185 1,664 1,473 1,102 1,121  
Balance sheet change%  -10.1% 40.4% -11.5% -25.1% 1.7%  
Added value  -100.7 685.0 135.3 -16.3 -2.7  
Added value %  0.0% 0.0% 3.6% -0.5% 0.0%  
Investments  -214 -73 -119 97 -136  
Net sales trend  0.0 0.0 0.0 -1.0 -2.0  
EBIT trend  -1.0 1.0 2.0 -1.0 -2.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 3.6% -0.4% 0.0%  
EBIT %  0.0% 0.0% 2.0% -2.4% 0.0%  
EBIT to gross profit (%)  -18.2% 30.0% 5.0% -6.3% -6.1%  
Net Earnings %  0.0% 0.0% 1.2% -4.1% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 2.8% -2.1% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 1.6% -3.0% 0.0%  
ROA %  -16.3% 44.2% 4.8% -5.9% -6.4%  
ROI %  -49.2% 123.3% 11.9% -13.9% -16.3%  
ROE %  -52.9% 124.3% 8.5% -34.3% -28.8%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  11.8% 35.7% 29.7% 28.0% 12.8%  
Relative indebtedness %  0.0% 0.0% 27.9% 24.8% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.8% 3.3% 0.0%  
Net int. bear. debt to EBITDA, %  377.2% -155.4% -490.8% 2,302.6% 4,587.1%  
Gearing %  110.9% 41.0% 77.8% 118.5% 243.5%  
Net interest  0 0 0 0 0  
Financing costs %  8.9% 19.4% 5.8% 5.1% 2.6%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.8 1.5 1.3 1.1 0.9  
Current Ratio  0.8 1.5 1.3 1.1 0.9  
Cash and cash equivalent  534.3 1,308.3 1,004.4 669.7 472.2  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 33.1 17.7 0.0  
Trade creditors turnover (days)  0.0 0.0 -22.8 -23.0 0.0  
Current assets / Net sales %  0.0% 0.0% 31.6% 21.1% 0.0%  
Net working capital  -143.2 259.0 60.0 -117.3 -277.9  
Net working capital %  0.0% 0.0% 1.6% -3.8% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 1,856 0 0  
Added value / employee  -50 342 68 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -50 342 68 0 0  
EBIT / employee  -104 313 38 0 0  
Net earnings / employee  -86 228 22 0 0